Botox for groin pain? small study explores new treatment

NCT ID NCT03496649

Terminated Symptom relief Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether injecting botulinum toxin A (Dysport) into the groin muscles could relieve chronic pain from adductor tendinopathy (pubalgia) in people who didn't get better with rest, anti-inflammatories, or physical therapy. Only 4 participants were enrolled before the study was stopped early. The goal was to see if this approach is worth studying further in larger trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Botulinum toxin A (Dysport) injection
What this could lead to: If this approach works, it could offer a new pain relief option for people with stubborn groin tendon pain that hasn't improved with standard treatments.
What could go wrong: This was a very small, early feasibility study that was terminated early, so results are limited. It's not yet proven to be safe or effective for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GROIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease of the tendon

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GROIN INJURY TENDINOPATHY

Contacts and locations

Locations

CHU de Bordeaux

Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.